A double-blind, randomized, placebo - controlled, pilot trial of individualized homoeopathic medicinesin Belching disorder in adults - nil

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. Patients who will fulfill ROME IV diagnostic criteria for belching disorders:
•a. Diagnostic Criteria for Belching Disorders Must include all the following: Bothersome
•(severe enough to impact on usual activities) belching from the esophagus or stomach
•more than 3 days a week.
•b. Criteria fulfilled for the last 3 months with symptom onset at least 6 months before
•2. Age between 18 and 65 years
•3. Patients of either sex including transgender
•4. Literate patients, ability to read English, Bengali or Hindi and illiterate people will be
•interviewed by the investigators maintaining adequate privacy to fill up the scales or
•questionnaires.
•5. Willing to take part in the study and give written informed assent and/or consent voluntarily

•1. Patient of known case of any disease ofstomach or having any pathological condition causing
•belching (e.g.: GERD, Peptic ulcer, Gastritis, Gastroparesis, Dumping syndrome etc.)
•2. Patients having any other systemic disease or having any life-threatening illness affecting
•quality of life or any other organ.
•3. Necessary relevant diagnostic tests will be advised to exclude Patients having any
•pathological conditions or organic diseases.
•4. Patients who are taking any medicines regularly for these complaints within last 6 weeks.
•5. Vulnerable population- Unconscious, ambulatory, too ill for consultation, differently abled,
•terminally ill or critically ill patients, institutionalized persons, mentally disabled people.
•6. Pregnant and postpartum women, nursing mothers.
•7. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other
•forms of substance abuse and/or dependence.
•8. Self-reported immune-compromised condition.
•9. Already been in homoeopathic treatment for any chronic illness for the last 6 months.
•10. Simultaneous participation in any other clinical trial.

发起方

The Calcutta Homoeopathic Medical College and Hospital